News chronological

Latest News Print

YOUTUBE (Fox Business) - VACCINE BREAKTHROUGH: Personalized cancer treatment takes major leap

Click to play Video
▶️

Moderna CEO Stéphane Bancel joins ‘Mornings with Maria’ to discuss the company's landmark cancer vaccine partnership with Merck. Bancel details the promising Phase 3 melanoma trial results and outlines Moderna's latest financial growth outlook. #foxbusiness #morningswithmaria 0:03 – Moderna and Merck’s Personalized Cancer Vaccine Breakthrough 1:18 – Moderna Targets FDA Approval for Next Year 2:20 – Expanding mRNA Cancer Treatment Beyond Melanoma 5:21 – Moderna’s mRNA Push: Rare Diseases and a New Flu Vaccine 7:27 – Personalized Vaccine Costs, Manufacturing and Moderna’s Growth Outlook

Sourcehttps://www.youtube.com/watch?v=kQ3K9-vXRSw
Keywordsmodernamerckcancer-vaccinemelanomamrnabiotechhealthcaremedicineoncologyclinical-trialsfdaimmunotherapystock-marketfinancetechfox-businessstephane-bancelmedical-breakthroughpharmabiotechnologypublic-healthusa
Notify Channelt.me/News_Wire
Permalinkhttps://news.site.please-be-patient.com/news/1137944/vaccine-breakthrough-personalized-cancer-treatment-takes-major-leap

Related article: FOX BUSINESS (Youtube): Moderna cancer vaccine BREAKTHROUGH drives new hope after phase 3 trial •

Related article: LIVENOW FROM FOX (Youtube): Moderna, Merck shares soar on success of mRNA cancer vaccine •

From related LIVENOW FROM FOX (Youtube): Moderna, Merck shares soar on success of mRNA cancer vaccine
When could the mRNA cancer vaccine be available to the public?
The vaccine could be available as soon as next year if regulators approve it.
Q&A ID e3a1a06c-ec33-4990-acd1-5caaf7cf8d29
From related LIVENOW FROM FOX (Youtube): Moderna, Merck shares soar on success of mRNA cancer vaccine
How does the mRNA cancer vaccine developed by Moderna and Merck work?
The vaccine works by training a patient’s immune system to recognize and attack specific mutations in cancer cells.
Q&A ID 2ec7a50f-c4f5-442e-a9dd-37234c5ff053
From related LIVENOW FROM FOX (Youtube): Moderna, Merck shares soar on success of mRNA cancer vaccine
What happened to Moderna and Merck's shares following the results of the mRNA cancer vaccine trial?
Moderna and Merck shares soared, with Moderna shares surging as much as 160% following the results.
Q&A ID 7ec05467-ebe1-4698-ac2c-dce27c62d1ef

Related article: AXIOS (Tina Reed): Moderna and Merck shares soar on mRNA cancer vaccine •

From related AXIOS (Tina Reed): Moderna and Merck shares soar on mRNA cancer vaccine
What safety findings were reported regarding the combination treatment of intismeran and Keytruda?
The safety profile of the combination treatment was consistent with earlier studies and showed no new risks. Moderna president Stephen Hoge noted that the findings showed early cancers might be treated more aggressively than with prior treatments that were more toxic to the body.
Q&A ID bfee9c1c-8c76-4a78-8378-ef53f4d70596
From related AXIOS (Tina Reed): Moderna and Merck shares soar on mRNA cancer vaccine
What was the market impact on Moderna following the decline in demand for its COVID vaccine post-pandemic?
Moderna's market value plummeted more than 90% after the demand for its COVID vaccine declined following the pandemic.
Q&A ID 7b501dbf-f6e1-4b19-a600-912ae22f5071
From related AXIOS (Tina Reed): Moderna and Merck shares soar on mRNA cancer vaccine
Besides skin cancer, what other types of cancer could the customized mRNA therapy potentially be adapted for?
The customized therapy could potentially be adapted for cancers of the kidney, bladder, and pancreas.
Q&A ID 3b8fc126-1e0d-4619-9a40-16cf98f4b10c
From related AXIOS (Tina Reed): Moderna and Merck shares soar on mRNA cancer vaccine
In what combination was Moderna's intismeran therapy tested and for which specific condition?
Intismeran was tested in combination with Merck's cancer drug Keytruda in more than 1,100 patients with high-risk melanoma that had been surgically removed. The combination showed a "clinically meaningful improvement" over treating the skin cancers with Keytruda alone.
Q&A ID 675de64d-09fd-4da1-845d-74caefa4b5e8

Related article: FOX BUSINESS (Youtube): Melanoma vaccine success: FDA approval soon #shorts •

Related article: HUFFPOST: Moderna, Merck mRNA Cancer Vaccine Cuts Recurrence And Spread Of Melanoma •

Related article: CNN (Youtube): Promising new treatment could mark breakthrough in cancer care •

Related article: NEWSNATIONNOW (Caroline Jaime): Cancer vaccine shows promise in late- stage melanoma trial; stocks soar •

From related NEWSNATIONNOW (Caroline Jaime): Cancer vaccine shows promise in late- stage melanoma trial; stocks soar
What type of cancer was the subject of the positive late-stage trial for the mRNA cancer vaccine announced by Moderna and Merck?
The trial was for a melanoma cancer vaccine.
Q&A ID 0a43643c-9b80-4daa-8bd1-b5a98028afa5
From related NEWSNATIONNOW (Caroline Jaime): Cancer vaccine shows promise in late- stage melanoma trial; stocks soar
What did Moderna and Merck announce on Wednesday, August 19, 2026, regarding their mRNA cancer vaccine?
Moderna and Merck announced that an mRNA cancer vaccine showed positive results in a late-stage melanoma trial.
Q&A ID 6fded44a-fd5e-44e8-9820-fb5d1caaafaa

Related article: NEWSNATION (Youtube): Inside the new experimental cancer vaccine doctors are calling ‘a big deal’ •

Related article: NYTIMES (Rebecca Robbins): Moderna’s Shift to Cancer Company Lifts Stock Up 177% •

From related NYTIMES (Rebecca Robbins): Moderna’s Shift to Cancer Company Lifts Stock Up 177%
What specific type of cancer is Moderna targeting as part of its strategic shift?
Moderna is shifting its focus toward cancer treatments, specifically targeting melanoma.
Q&A ID 1fc3fb38-4764-40ab-ac76-e05e6aaa1ac9
From related NYTIMES (Rebecca Robbins): Moderna’s Shift to Cancer Company Lifts Stock Up 177%
How much has Moderna's stock price increased following its strategic shift toward cancer treatments?
Moderna's stock has risen by 177% as the company pivots from focusing on Covid-19 vaccines to cancer treatments, specifically targeting melanoma.
Q&A ID 92b6357f-ccd9-43f9-b023-6c32cb9265e0

Related article: JUSTTHENEWS (Greg Piper): Science by press release: Moderna cashes in on mRNA cancer vaccine without publishing trial results •

Related article: NEWSNATION (Youtube): FDA to consider Moderna’s new mRNA flu vaccine •

Related article: NEWSNATION (Youtube): Moderna says FDA won't review its mRNA flu shot | Morning in America •

Related article: JUSTTHENEWS (Natalia Mittelstadt): Moderna says FDA reversing course, will review mRNA flu shot •

Related article: HUFFPOST: New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence •

Related article: NYTIMES (Carolyn Y. Johnson): Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning •

From related NYTIMES (Carolyn Y. Johnson): Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Which companies are involved in the development of the mRNA vaccine that prevents the return and spread of melanoma?
The companies involved are Moderna and Merck.
Q&A ID f9e237e6-2594-4e4d-beb4-df4354db86d4
From related NYTIMES (Carolyn Y. Johnson): Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
What have Moderna and Merck reported regarding their mRNA vaccine's effect on melanoma?
Moderna and Merck have stated that their mRNA vaccine prevented the return and spread of melanoma in high-risk patients.
Q&A ID 035d9962-8e0c-4e2d-a60d-92b5e1f91975

Related article: FOX BUSINESS (Youtube): This is a NICE SURPRISE for the market, CEO says •

Related article: AMERICANGREATNESS: Morning Greatness: FDA Approves Moderna’s mRNA Seasonal Flu Vaccine •

Related article: JUSTTHENEWS (Natalia Mittelstadt): FDA declines to review Moderna's mRNA flu shot application •

Related article: JUSTTHENEWS (Kevin Killough): Cancer vaccine shows promise in preventing recurrance of melanoma, Merck and Moderna say •

From related JUSTTHENEWS (Kevin Killough): Cancer vaccine shows promise in preventing recurrance of melanoma, Merck and Moderna say
What have Merck and Moderna reported regarding their cancer vaccine trial for melanoma?
Merck and Moderna have stated that their vaccine-drug combination shows promise in preventing the recurrence of melanoma. Interim results from the trial indicated that the combination appeared to increase the time before cancer returned in high-risk patients.
Q&A ID 0bf7372e-5395-47fd-ae3e-985aef7e3b22

Related article: FOX BUSINESS (Youtube): New drug shows promise for lung cancer •

Latest News